Serum pro-collagen III peptide levels are related to lobular necrosis in untreated patients with chronic hepatitis C

被引:15
作者
Giannini, E [1 ]
Caglieris, S [1 ]
Ceppa, P [1 ]
Risso, D [1 ]
Lantieri, PB [1 ]
Testa, R [1 ]
机构
[1] Univ Genoa, Dept Internal Med, Gastroenterol Unit, I-16132 Genoa, Italy
关键词
chronic hepatitis C; fibrosis; histology; lobular necrosis; pro-collagen III peptide;
D O I
10.1097/00042737-200102000-00008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective Liver biopsy is mandatory for correctly grading and staging chronic hepatitis activity. Nevertheless, serum markers of fibrogenesis may be useful to help us understand the mechanisms of the fibrogenic process, to follow-up patients, and to establish the efficacy of therapy. In this study, our aim was to identify the relationships between pro-collagen III peptide (PIIIP) serum levels and detailed liver histology in a group of untreated patients with chronic hepatitis C (CHC). Methods We studied 147 CHC patients. Correlation analysis of PIIIP serum levels was performed in 109 patients, after having excluded those with alcohol abuse or concomitant hepatitis B virus infection. PIIIP serum levels were assessed using an assay that measures both Col 1-3 peptide (reflecting collagen synthesis) and Col 1 peptide (reflecting collagen degradation). Relationships of serum PIIIP with histology was carried out by evaluating grading and staging separately. Moreover, each component of the necro-inflammatory score was also taken into consideration. Results PIIIP levels were abnormal in 101 patients (93%). Moreover, PIIIP levels were no different between patients with (12.1 +/- 6.3 ng/ml) or without (13 +/- 5.8 ng/ml) fibrosis. In univariate analysis, no relationship was observed with fibrosis (r(s) = 0.033, not significant), while PIIIP levels were significantly correlated with lobular necrosis only (r(s) = 0.295, P = 0.0020). Multivariate analysis confirmed this latter finding (P = 0.0150). Among biochemical parameters, PIIIP showed relationships with aminotransferase (AST, r(s) = 0.294, P = 0.0022; ALT, r(s) = 0.236, P = 0.0142) and alkaline phosphatase (r(s) = 0.146, P = 0.0223). Conclusions In patients with CHC, serum PIIIP levels reflect histological parameters strictly related to fibrogenesis, Therefore, PIIIP is a useful tool to evaluate ongoing fibrogenic activity of CHC. A complete histological score is needed in order to understand the relationships between biochemical markers of fibrogenesis and histology. Eur J Gastroenterol Hepatol 13:137-141 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:137 / 141
页数:5
相关论文
共 25 条
  • [1] Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C
    Baroni, GS
    Pastorelli, A
    Manzin, A
    Benedetti, A
    Marucci, L
    Solfarosi, L
    Di Sario, A
    Brunelli, E
    Orlandi, F
    Clementi, M
    Macarri, G
    [J]. LIVER, 1999, 19 (03): : 212 - 219
  • [2] RANDOMIZED TRIAL OF LYMPHOBLASTOID ALPHA-INTERFERON IN CHRONIC HEPATITIS-C - EFFECTS ON INFLAMMATION, FIBROGENESIS AND VIREMIA
    CAMPS, J
    CASTILLA, A
    RUIZ, J
    CIVEIRA, MP
    PRIETO, J
    [J]. JOURNAL OF HEPATOLOGY, 1993, 17 (03) : 390 - 396
  • [3] ALPHA-INTERFERON IN THE TREATMENT OF CHRONIC VIRAL-HEPATITIS - EFFECTS ON FIBROGENESIS SERUM MARKERS
    CAPRA, F
    CASARIL, M
    GABRIELLI, GB
    TOGNELLA, P
    RIZZI, A
    DOLCI, L
    COLOMBARI, R
    MEZZELANI, P
    CORROCHER, R
    DESANDRE, G
    [J]. JOURNAL OF HEPATOLOGY, 1993, 18 (01) : 112 - 118
  • [4] TRANSFORMING GROWTH FACTOR-BETA-1 AND FACTOR-ALPHA IN CHRONIC LIVER-DISEASE - EFFECTS OF INTERFERON ALFA THERAPY
    CASTILLA, A
    PRIETO, J
    FAUSTO, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) : 933 - 940
  • [5] *CONS PAN, 1999, J HEPATOL, V30, P956
  • [6] DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
  • [7] The natural course of chronic hepatitis C: implications for clinical practice
    Dusheiko, GM
    [J]. JOURNAL OF VIRAL HEPATITIS, 1998, 5 : 9 - 12
  • [8] Fibrogenesis serum markers in patients with chronic hepatitis C treated with α-IFN
    Fabris, P
    Marranconi, F
    Bozzola, L
    Biasin, MR
    De Lazzari, F
    Plebani, M
    Benedetti, P
    Tositti, G
    Pellizzer, G
    Stecca, C
    de Lalla, F
    [J]. JOURNAL OF GASTROENTEROLOGY, 1999, 34 (03) : 345 - 350
  • [9] THE N-TERMINAL PROPEPTIDE OF COLLAGEN TYPE-III IN SERUM REFLECTS ACTIVITY AND DEGREE OF FIBROSIS IN PATIENTS WITH CHRONIC LIVER-DISEASE
    FREI, A
    ZIMMERMANN, A
    WEIGAND, K
    [J]. HEPATOLOGY, 1984, 4 (05) : 830 - 834
  • [10] SERUM MARKERS OF HEPATIC FIBROGENESIS IN CHRONIC HEPATITIS TYPE-C TREATED WITH ALFA-2A INTERFERON
    GALLORINI, A
    PLEBANI, M
    PONTISSO, P
    CHEMELLO, L
    MASIERO, M
    MANTOVANI, G
    ALBERTI, A
    [J]. LIVER, 1994, 14 (05): : 257 - 264